Michael P Gustafson

6PUBLICATIONS
46CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 11, 2026
Clinical Evaluation of Ex Vivo Expanded MUC1-Specific Peripheral Blood T Cells for Adoptive Immunotherapy in Relapsed/Refractory Multiple Myeloma.

|May 20, 2026
Cellular Therapies in Solid Tumors: Are We Ready for Primetime?

|Jan 09, 2024
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy.

Bruce L Levine, Marcelo C Pasquini, John E Connolly

|Jul 28, 2023
Image-based models of T-cell distribution identify a clinically meaningful response to a dendritic cell vaccine in patients with glioblastoma.

Kamila M Bond, Lee Curtin, Andrea Hawkins-Daarud

|Oct 15, 2020
Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.

Matthew S Block, Allan B Dietz, Michael P Gustafson

|Nov 24, 2019
Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine.

Keith L Knutson, Matthew S Block, Nadine Norton

Pageof 1

Frequent Collaborators

1 joint publications

Amylou C Dueck

1 joint publications

Matthew S Block

1 joint publications

Kevin D Pavelko

1 joint publications

Aminah Jatoi